Design and performance of hemostatic biomaterials for managing hemorrhaging

Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2018. === Cataloged from PDF version of thesis. === Includes bibliographical references. === The high mortality rates associated with uncontrolled bleeding motivate hemostatic material development for trauma...

Full description

Bibliographic Details
Main Author: Avery, Reginald Keith
Other Authors: Bradley D. Olsen.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2019
Subjects:
Online Access:http://hdl.handle.net/1721.1/120898
id ndltd-MIT-oai-dspace.mit.edu-1721.1-120898
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-1208982019-05-02T16:36:39Z Design and performance of hemostatic biomaterials for managing hemorrhaging Avery, Reginald Keith Bradley D. Olsen. Massachusetts Institute of Technology. Department of Biological Engineering. Massachusetts Institute of Technology. Department of Biological Engineering. Biological Engineering. Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2018. Cataloged from PDF version of thesis. Includes bibliographical references. The high mortality rates associated with uncontrolled bleeding motivate hemostatic material development for traumatic injuries. Uncontrolled, or hemorrhagic, internal bleeding requires hemostatic materials that can be directly delivered to or target the bleeding locations. To address these needs, injectable systems are being developed that: (1) generate artificial clots independent of the coagulation cascade or (2) interact with blood components to accelerate or otherwise improve coagulation processes. Hemostatic materials designed for internal bleeding can save lives in the battlefield, en route to emergency rooms, and in the operating room. This thesis first focuses on developing a shear-thinning hydrogel for injection onto bleeding surfaces and into ruptured vasculature. Based on in vitro assays of hydrogel performance, it was amenable to clinical delivery methods and reduced whole blood clotting times by 77%. In vivo bleeding models showed reduced blood loss and improved survival rates following a lethal liver injury. The hydrogel was also used as an embolic agent, where its occlusive potential in an anticoagulated model was demonstrated. Next, recombinant protein-based hemostatic materials were expressed to modulate clotting kinetics and performance. By incorporating clot interacting peptide sequences (CIPs) into a protein scaffold, a family of multifunctional fibrinogen like proteins (MFLPs) was developed and assayed. Clot turbidity, an indication of fibrin clot formation, was increased among enzyme-interacting CIPs. Mimicking the polymerization mechanism of fibrinogen, knob sequences were shown to be procoagulant at low concentrations by increasing clot turbidity, reducing clotting times, and inhibiting plasmin lysis. Finally, to understand the impact of hemostats on clot structure, imaging procedures were developed to systematically assess hemostatic materials and their influence on clot architecture. Static and dynamic approaches were developed to quantify the activity of hemostats based on the spatial distribution of fibrinogen, red blood cells, and platelets around hemostat surfaces. Quantification of these hemostat-blood component interactions resulted in a unique pattern of interactions for each hemostat studied. These techniques could serve as a screening technique for hemostats and improve characterization prior to in vivo assays. Taken together, the results highlight multiple approaches to address internal bleeding and opportunities to improve in vitro characterization of hemostats using microscopy. by Reginald Keith Avery. Ph. D. 2019-03-11T19:36:39Z 2019-03-11T19:36:39Z 2018 2018 Thesis http://hdl.handle.net/1721.1/120898 1088892797 eng MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission. http://dspace.mit.edu/handle/1721.1/7582 326 pages application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Biological Engineering.
spellingShingle Biological Engineering.
Avery, Reginald Keith
Design and performance of hemostatic biomaterials for managing hemorrhaging
description Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2018. === Cataloged from PDF version of thesis. === Includes bibliographical references. === The high mortality rates associated with uncontrolled bleeding motivate hemostatic material development for traumatic injuries. Uncontrolled, or hemorrhagic, internal bleeding requires hemostatic materials that can be directly delivered to or target the bleeding locations. To address these needs, injectable systems are being developed that: (1) generate artificial clots independent of the coagulation cascade or (2) interact with blood components to accelerate or otherwise improve coagulation processes. Hemostatic materials designed for internal bleeding can save lives in the battlefield, en route to emergency rooms, and in the operating room. This thesis first focuses on developing a shear-thinning hydrogel for injection onto bleeding surfaces and into ruptured vasculature. Based on in vitro assays of hydrogel performance, it was amenable to clinical delivery methods and reduced whole blood clotting times by 77%. In vivo bleeding models showed reduced blood loss and improved survival rates following a lethal liver injury. The hydrogel was also used as an embolic agent, where its occlusive potential in an anticoagulated model was demonstrated. Next, recombinant protein-based hemostatic materials were expressed to modulate clotting kinetics and performance. By incorporating clot interacting peptide sequences (CIPs) into a protein scaffold, a family of multifunctional fibrinogen like proteins (MFLPs) was developed and assayed. Clot turbidity, an indication of fibrin clot formation, was increased among enzyme-interacting CIPs. Mimicking the polymerization mechanism of fibrinogen, knob sequences were shown to be procoagulant at low concentrations by increasing clot turbidity, reducing clotting times, and inhibiting plasmin lysis. Finally, to understand the impact of hemostats on clot structure, imaging procedures were developed to systematically assess hemostatic materials and their influence on clot architecture. Static and dynamic approaches were developed to quantify the activity of hemostats based on the spatial distribution of fibrinogen, red blood cells, and platelets around hemostat surfaces. Quantification of these hemostat-blood component interactions resulted in a unique pattern of interactions for each hemostat studied. These techniques could serve as a screening technique for hemostats and improve characterization prior to in vivo assays. Taken together, the results highlight multiple approaches to address internal bleeding and opportunities to improve in vitro characterization of hemostats using microscopy. === by Reginald Keith Avery. === Ph. D.
author2 Bradley D. Olsen.
author_facet Bradley D. Olsen.
Avery, Reginald Keith
author Avery, Reginald Keith
author_sort Avery, Reginald Keith
title Design and performance of hemostatic biomaterials for managing hemorrhaging
title_short Design and performance of hemostatic biomaterials for managing hemorrhaging
title_full Design and performance of hemostatic biomaterials for managing hemorrhaging
title_fullStr Design and performance of hemostatic biomaterials for managing hemorrhaging
title_full_unstemmed Design and performance of hemostatic biomaterials for managing hemorrhaging
title_sort design and performance of hemostatic biomaterials for managing hemorrhaging
publisher Massachusetts Institute of Technology
publishDate 2019
url http://hdl.handle.net/1721.1/120898
work_keys_str_mv AT averyreginaldkeith designandperformanceofhemostaticbiomaterialsformanaginghemorrhaging
_version_ 1719043786678468608